all investments current investments previous investments


Medical Technology company developing a device to improve the care of type 2 diabetic patients.


Developing the next generation treatment for brain aneurysms


PneumRx is developing and marketing minimally invasive therapeutic devices to treat emphysema patients.


Symetis has developed a minimally invasive Transcatheter Aortic Valve Implantation (TAVI) system to treat patients suffering from aortic valve stenosis.
 


Medical technology company with a device to treat morbid obese patients. A gastric band restricts food intake, and is remotely controlled by the medical doctor. Company sold to Allergan (AGN) in February 2007.


Fully automated system for molecular biology diagnostis enablking easy DNA extraction and fast detection of bacteria.


Develop, manufacture, and market dental implant systems. Sold participation in January 2006.
  


Medical Technology company developing a device to improve the care of type 2 diabetic patients.


Medical technology company with a device to treat morbid obese patients. A gastric band restricts food intake, and is remotely controlled by the medical doctor. Company sold to Allergan (AGN) in February 2007.


Fully automated system for molecular biology diagnostis enablking easy DNA extraction and fast detection of bacteria.


Developing the next generation treatment for brain aneurysms


PneumRx is developing and marketing minimally invasive therapeutic devices to treat emphysema patients.


Symetis has developed a minimally invasive Transcatheter Aortic Valve Implantation (TAVI) system to treat patients suffering from aortic valve stenosis.


Develop, manufacture, and market dental implant systems. Sold participation in January 2006.
   
© Endeavour Vision SA 2006-2012 Terms & Conditions